AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Hims & Hers faces lawsuit over allegedly deceptive weight loss medication sales.
ByAinvest
Monday, Aug 4, 2025 8:51 am ET1min read
The Gross Law Firm is seeking shareholders of Hims & Hers Health to contact them regarding possible lead plaintiff appointment. The firm alleges that the company issued false and/or misleading statements during the class period of April 29, 2025 to June 23, 2025, including deceptive promotion and selling of illegitimate versions of Wegovy and a substantial risk that the company's collaboration with Novo Nordisk would be terminated. Shareholders are encouraged to contact the firm regarding possible lead plaintiff appointment.
NEW YORK, Aug. 4, 2025 /PRNewswire/ — The Gross Law Firm has issued a notice to shareholders of Hims & Hers Health Inc. (NYSE: HIMS), alleging securities law violations. The firm is seeking shareholders who purchased shares during the class period from April 29, 2025, to June 23, 2025, to contact them regarding possible lead plaintiff appointment [1].The complaint alleges that during the class period, Hims & Hers Health Inc. issued materially false and/or misleading statements and failed to disclose that:
1. The company was engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk" [2].
2. There was a substantial risk that the company's collaboration with Novo Nordisk would be terminated.
3. Defendants' positive statements about the company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Shareholders are encouraged to contact the Gross Law Firm before August 25, 2025, to discuss their rights [1]. The firm offers portfolio monitoring software to provide shareholders with status updates throughout the case's lifecycle. There is no cost or obligation to participate in the case.
The Gross Law Firm is a nationally recognized class action law firm committed to protecting investors' rights. The firm seeks recovery on behalf of shareholders who incurred losses due to false and/or misleading statements or the omission of material information [1].
References:
[1] https://www.prnewswire.com/news-releases/hims--hers-health-inc-sued-for-securities-law-violations---contact-the-gross-law-firm-before-august-25-2025-to-discuss-your-rights--hims-302520050.html
[2] https://www.marketscreener.com/news/hims-hers-health-inc-sued-for-securities-law-violations-contact-the-gross-law-firm-before-augu-ce7c5edadf8bfe20
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet